Jin Medical International-AZJYL

13F holders, Q4 2024 (December 31)
10holders −2
2new positions
4sold out
$0.78avg. 13F price*

At the end of Q4 2024, 10 institutions reported holding Jin Medical International-A (ZJYL) in their 13F filings, down 2 from Q3 2024. 2 opened new positions and 4 sold out. The largest holders were Vanguard Group Inc. ($1.1M), UBS Group AG ($149K) and Invesco Ltd. ($99K).

Company
Jin Medical International-A
CUSIP
G5140V112
Latest filing quarter
Q4 2025

History

Number of 13F holders

05101520 Q1 2024: 17Q1 2024Q2 2024: 12Q2 2024Q3 2024: 12Q3 2024Q4 2024: 10Q4 2024Q1 2025: 17Q1 2025Q2 2025: 13Q2 2025Q3 2025: 9Q3 2025Q4 2025: 10Q4 2025

Total Exit/New Position Q3 2024 → Q4 2024

InstitutionsTotal Value
New Positions2$29K
Exits4$238K

All 13F filers, Q3 2024 → Q4 2024: 234,802 shares bought and 91,397 shares sold, net +143,405 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.

Ownership 10 holders

Vanguard Group Inc. 0.00% No change 1,448,484 $1.1M
UBS Group AG 0.00% Add +9013.7% 191,023 $149K
Invesco Ltd. 0.00% Reduce -0.9% 127,100 $99K
Geode Capital Management, LLC 0.00% No change 106,540 $83K
Two Sigma Investments, LP 0.00% New 32,794 $26K
Osaic Holdings, Inc. 0.00% Add +186.5% 13,980 $11K
Tower Research Capital LLC (TRC) 0.00% New 3,981 $3K
Morgan Stanley 0.00% Reduce -83.9% 339 $264
Bell Investment Advisors, Inc 0.00% No change 152 $119
WealthCollab, LLC 0.00% No change 23 $18

"% of holder's portfolio" is ZJYL's weight in each manager's 13F, not the share of Jin Medical International-A the manager owns.